Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15937 | 683 | 39.1 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
304 | 3 | P53//RETINOBLASTOMA//MDM2 | 40663 |
483 | 2 | CYCLIN DEPENDENT KINASE//CELL CYCLE//CDK5 | 15640 |
15937 | 1 | CDC25B//CDC25 PHOSPHATASE//CDC25A | 683 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CDC25B | authKW | 1497386 | 8% | 59% | 57 |
2 | CDC25 PHOSPHATASE | authKW | 914430 | 4% | 68% | 30 |
3 | CDC25A | authKW | 606574 | 6% | 32% | 42 |
4 | CDC25 INHIBITORS | authKW | 584162 | 2% | 93% | 14 |
5 | VITAMIN K2 | authKW | 390134 | 4% | 36% | 24 |
6 | CDC25 | authKW | 310615 | 5% | 19% | 37 |
7 | P423 | authKW | 238429 | 1% | 67% | 8 |
8 | LBCMCP | address | 196673 | 3% | 20% | 22 |
9 | CDC25B PHOSPHATASE | authKW | 182545 | 1% | 58% | 7 |
10 | LBCMCP UMR5088 | address | 156465 | 1% | 50% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2245 | 31% | 0% | 209 |
2 | Cell Biology | 1170 | 22% | 0% | 153 |
3 | Chemistry, Medicinal | 1016 | 12% | 0% | 82 |
4 | Biochemistry & Molecular Biology | 708 | 29% | 0% | 201 |
5 | Chemistry, Organic | 190 | 9% | 0% | 62 |
6 | Genetics & Heredity | 132 | 7% | 0% | 49 |
7 | Pharmacology & Pharmacy | 124 | 10% | 0% | 71 |
8 | Gastroenterology & Hepatology | 61 | 4% | 0% | 25 |
9 | Medicine, Research & Experimental | 33 | 4% | 0% | 26 |
10 | Biophysics | 29 | 4% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LBCMCP | 196673 | 3% | 20% | 22 |
2 | LBCMCP UMR5088 | 156465 | 1% | 50% | 7 |
3 | BIOL CHEM FUNDAMENTAL MED | 102183 | 1% | 57% | 4 |
4 | UMR5088 | 91266 | 1% | 29% | 7 |
5 | IFR109 EXPLORAT FONCT GENOMES | 89413 | 0% | 100% | 2 |
6 | DRUGS SCREENING | 80469 | 0% | 60% | 3 |
7 | STARZL TRANSPLANTAT | 65858 | 2% | 11% | 14 |
8 | LIVER CANC SURG | 59607 | 0% | 67% | 2 |
9 | UA4124 | 59607 | 0% | 67% | 2 |
10 | IPSEN | 46597 | 1% | 15% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 5062 | 2% | 1% | 11 |
2 | ONCOGENE | 2045 | 4% | 0% | 29 |
3 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1495 | 3% | 0% | 18 |
4 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 1287 | 2% | 0% | 12 |
5 | VITAMINS AND HORMONES-ADVANCES IN RESEARCH AND APPLICATIONS | 1079 | 0% | 1% | 3 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 987 | 4% | 0% | 24 |
7 | SELECTIVE CANCER THERAPEUTICS | 731 | 0% | 2% | 1 |
8 | MOLECULAR CANCER THERAPEUTICS | 526 | 1% | 0% | 7 |
9 | JOURNAL OF CELLULAR PHYSIOLOGY | 520 | 2% | 0% | 11 |
10 | CANCER RESEARCH | 473 | 3% | 0% | 21 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CDC25B | 1497386 | 8% | 59% | 57 | Search CDC25B | Search CDC25B |
2 | CDC25 PHOSPHATASE | 914430 | 4% | 68% | 30 | Search CDC25+PHOSPHATASE | Search CDC25+PHOSPHATASE |
3 | CDC25A | 606574 | 6% | 32% | 42 | Search CDC25A | Search CDC25A |
4 | CDC25 INHIBITORS | 584162 | 2% | 93% | 14 | Search CDC25+INHIBITORS | Search CDC25+INHIBITORS |
5 | VITAMIN K2 | 390134 | 4% | 36% | 24 | Search VITAMIN+K2 | Search VITAMIN+K2 |
6 | CDC25 | 310615 | 5% | 19% | 37 | Search CDC25 | Search CDC25 |
7 | P423 | 238429 | 1% | 67% | 8 | Search P423 | Search P423 |
8 | CDC25B PHOSPHATASE | 182545 | 1% | 58% | 7 | Search CDC25B+PHOSPHATASE | Search CDC25B+PHOSPHATASE |
9 | CDC25B INHIBITOR | 143059 | 1% | 80% | 4 | Search CDC25B+INHIBITOR | Search CDC25B+INHIBITOR |
10 | MENADIONE | 134364 | 5% | 8% | 36 | Search MENADIONE | Search MENADIONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BOUTROS, R , LOBJOIS, V , DUCOMMUN, B , (2007) CDC25 PHOSPHATASES IN CANCER CELLS: KEY PLAYERS? GOOD TARGETS?.NATURE REVIEWS CANCER. VOL. 7. ISSUE 7. P. 495-507 | 84 | 57% | 313 |
2 | LAVECCHIA, A , DI GIOVANNI, C , NOVELLINO, E , (2012) CDC25 PHOSPHATASE INHIBITORS: AN UPDATE.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 1. P. 62 -73 | 53 | 79% | 34 |
3 | GARUTI, L , ROBERTI, M , PIZZIRANI, D , (2008) SYNTHETIC SMALL MOLECULE CDC25 PHOSPHATASES INHIBITORS.CURRENT MEDICINAL CHEMISTRY. VOL. 15. ISSUE 6. P. 573-580 | 47 | 89% | 7 |
4 | LAVECCHIA, A , DI GIOVANNI, C , NOVELLINO, E , (2009) CDC25A AND B DUAL-SPECIFICITY PHOSPHATASE INHIBITORS: POTENTIAL AGENTS FOR CANCER THERAPY.CURRENT MEDICINAL CHEMISTRY. VOL. 16. ISSUE 15. P. 1831-1849 | 62 | 58% | 19 |
5 | SUR, S , AGRAWAL, DK , (2016) PHOSPHATASES AND KINASES REGULATING CDC25 ACTIVITY IN THE CELL CYCLE: CLINICAL IMPLICATIONS OF CDC25 OVEREXPRESSION AND POTENTIAL TREATMENT STRATEGIES.MOLECULAR AND CELLULAR BIOCHEMISTRY. VOL. 416. ISSUE 1-2. P. 33 -46 | 50 | 57% | 1 |
6 | KRISTJANSDOTTIR, K , RUDOLPH, J , (2004) CDC25 PHOSPHATASES AND CANCER.CHEMISTRY & BIOLOGY. VOL. 11. ISSUE 8. P. 1043-1051 | 42 | 74% | 193 |
7 | LAVECCHIA, A , DI GIOVANNI, C , NOVELLINO, E , (2010) INHIBITORS OF CDC25 PHOSPHATASES AS ANTICANCER AGENTS: A PATENT REVIEW.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 20. ISSUE 3. P. 405-425 | 48 | 59% | 33 |
8 | LAVECCHIA, A , COLUCCIA, A , DI GIOVANNI, C , NOVELLINO, E , (2008) CDC25B PHOSPHATASE INHIBITORS IN CANCER THERAPY: LATEST DEVELOPMENTS, TRENDS AND MEDICINAL CHEMISTRY PERSPECTIVE.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 8. P. 843-856 | 56 | 57% | 8 |
9 | BOUTROS, R , DOZIER, C , DUCOMMUN, B , (2006) THE WHEN AND WHERES OF CDC25 PHOSPHATASES.CURRENT OPINION IN CELL BIOLOGY. VOL. 18. ISSUE 2. P. 185-191 | 40 | 59% | 268 |
10 | LYON, MA , DUCRUET, AP , WIPF, P , LAZO, JS , (2002) DUAL-SPECIFICITY PHOSPHATASES AS TARGETS FOR ANTINEOPLASTIC AGENTS.NATURE REVIEWS DRUG DISCOVERY. VOL. 1. ISSUE 12. P. 961 -976 | 61 | 51% | 100 |
Classes with closest relation at Level 1 |